Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options If you...
-
Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Frost Radar: Workforce Engagement Management, 2025" report has been added to ResearchAndMarkets.com's offering.A Benchmarking System to Spark...
-
AGMH secured $25M ELOC and convertible notes; funds fuel AI ASIC chip R&D and global supply chain development, advancing its AI industrial chain layout.
-
Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "Understanding and Managing Contracts to Achieve Better Results Training Course (April 15-16, 2026)" training has been added to ...
-
St. Petersburg, Fla., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Record client assets under administration of $1.77 trillion and record Private Client Group assets in fee-based accounts of $1.04...
-
Proprietary trading firm strengthens global footprint amid industry reset and shift away from challenge-based models
-
SAN FRANCISCO and SYDNEY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Fundbox, the leading provider of embedded capital infrastructure for small businesses, today announced its expansion into Australia,...
-
Austin, TX, USA, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Life Insurance Policy Administration Systems Market Size, Trends and Insights By...
-
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...
-
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...